69
Participants
Start Date
November 12, 2018
Primary Completion Date
August 3, 2020
Study Completion Date
November 25, 2020
AL002
Single-doses of AL002 in up to 9 dose-escalating cohorts
Saline Solution
Saline solution will be administered as a single infusion for each cohort in a ratio of 6 active and 2 placebo subjects for HV and 10 active and 2 placebo for patients
Columbia University, New York
Compass Research - The Villages, The Villages
Compass Research - Orlando, Orlando
Brain Matters Research, Delray Beach
Nucleus Network Pty Ltd, Melbourne
University College London, London
Lead Sponsor
Alector Inc.
INDUSTRY